1. Name of Activity / Session
Month day, year

2. Disclosure of Financial Support
This program has received financial support from AMOSO in the form of an AFP Innovation Fund Educational Grant.
Potential for conflict(s) of interest:
Dr. Eric Wong (Scientific Planning Committee Member) has received honoraria from Bayer Canada for real-life role play training in 2018 and He was also a member of the Advisory Board for Bayer Canada in 2018.
Dr. Eric Wong has also acted as an assessor for the CPSO, Academic Consultant and Teacher for Touchstone Institute, and Medical Director for Thames Valley Family Health Team
This slide must be visually presented to the audience AND verbalized by the speaker. Where a program has received no external funding or in-kind support, indicate No External Support.
An AHSC AFP Innovation Fund Education Grant was used to fund the development of this course.
This slide only needs to be disclosed in the * first * session.

3. Mitigating Potential Bias
Conflict of interest disclosure forms were collected as early as possible within the planning process and disseminated to the Scientific Planning Committee.
Therapeutic recommendations for medications will not be a part of this course.
Exclusivity and branding for therapeutic options will not be reflected in this course.
Sponsors were not involved in the planning, development or delivery of this course.
This slide must be visually presented to the audience AND verbalized by the speaker.
This slide only needs to be disclosed in the * first * session.

4. Faculty Disclosure (Session 1)
“We have not in the past 2 years, had a financial interest, arrangement or affiliation with one or more organizations that could be perceived as a direct/indirect conflict of interest in the content of the subject of this or any other program.”
Session 1: September 24
Chris Watling, Michael Sanatani

5. Faculty Disclosure (Session 2)
“We have not in the past 2 years, had a financial interest, arrangement or affiliation with one or more organizations that could be perceived as a direct/indirect conflict of interest in the content of the subject of this or any other program.”
Session 2: November 19
David McLean

6. Faculty Disclosure (Session 3)
“We have not in the past 2 years, had a financial interest, arrangement or affiliation with one or more organizations that could be perceived as a direct/indirect conflict of interest in the content of the subject of this or any other program.”
Session 3: January 21
Kylea Potvin

7. Faculty Disclosure (Session 4)
“We have not in the past 2 years, had a financial interest, arrangement or affiliation with one or more organizations that could be perceived as a direct/indirect conflict of interest in the content of the subject of this or any other program.”
Session 4: March 24
Chris Watling

8. Faculty Disclosure (Session 5)
“We have not in the past 2 years, had a financial interest, arrangement or affiliation with one or more organizations that could be perceived as a direct/indirect conflict of interest in the content of the subject of this or any other program.”
Session 5: May 12
Julie Ann Van Koughnett

9. Faculty Disclosure (Session 6)
“We have not in the past 2 years, had a financial interest, arrangement or affiliation with one or more organizations that could be perceived as a direct/indirect conflict of interest in the content of the subject of this or any other program.”
Session 6: June 16
Chris Watling, Kylea Potvin, Marta Wilejto, Michael Sanatani